Ethan M. Clement
Researcher
Also affiliated: Centre National de la Recherche Scientifique (2023); University of Toronto (1976); University of Arkansas Medical Center (2023); Mount Desert Island Biological Laboratory (2009–2010); Warneford Hospital (1998–2002); University of Oxford (1983–2002); Translational Innovation in Medicine and Complexity (2023); Littlemore Hospital (1996); University of Glasgow (1977–1980); Université Grenoble Alpes (2023)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Ethan M. Clement's research focuses on neurological disorders and treatments, with recent publications investigating the vulnerability of specific interneurons in mouse models of temporal lobe epilepsy and syndecan-1's role in myeloma aggressiveness. Clement has authored 29 publications, accumulating 708 citations and an h-index of 12. Their work also touches upon broader health and medical research impacts, as indicated by the inclusion of MeSH terms such as Humans, Female, Male, and various animal models in their scholarly output.
Metrics
- h-index: 12
- Publications: 29
- Citations: 727
Selected Publications
-
A 61‐year‐old with heavy tobacco use (2023)
-
Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy (2021)
-
Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant Neurons (2020)
-
Contributors (2019)
-
The critical role of persistent sodium current in hippocampal gamma oscillations (2019)
-
Epilepsy and arousal (2019)
-
Group I metabotropic glutamate receptors generate two types of intrinsic membrane oscillations in hippocampal oriens/alveus interneurons (2018)
Collaboration Network
Top Collaborators
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
- A 61‐year‐old with heavy tobacco use
Similar Researchers
Based on overlapping research topics